FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: December 31, 2014 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person * Tadmor-Eilat Zohar (Last) (First) (Middle) 94 SHLOMO SHMELZER ROAD (Street) PETAH TIKVA 4970602 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026	3. Issuer Name and Ticker or Trading Symbol Cellebrite DI Ltd. [ CLBT ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief People Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	129,814 (1) (2) (3) (4) (5)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock options	(6)	02/13/2033	Ordinary Shares	22,722	4.95	D
Stock options	(7)	03/19/2034	Ordinary Shares	28,236	11.51	D

Explanation of Responses:

1. Includes 21,988 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on February 14, 2023, of which 5,497 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

2. Includes 15,615 Ordinary Shares that are represented by RSUs that were granted on March 20, 2024, of which 1,735 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.

3. Includes 11,760 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 980 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029.

4. Includes 3,471 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on March 20, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through March 20, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.

5. Includes 39,491 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 9,875 vest on the first anniversary of the grant date and 2,468 vest every three months thereafter through February 10, 2030.

6. Of these stock options, 7,574 are fully vested and exercisable and 3,787 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027.

7. Of these stock options, 12,360 are fully vested and exercisable and 1,764 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.

	/s/ Zohar Tadmor-Eilat	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.